Inhalation Sciences: Continued High Activity in the IRS Segment

Research Note

2022-03-18

11:00

Redeye endorses ISAB signing yet another IRS contract worth around SEK 773,000 (EUR 74,000). The contract is for a research project with a leading Swiss developer of inhaled generics. We are encouraged by the continued high activity in the IRS segment and retain our long-term positive view of ISAB.

Erik Nordström

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.